A new study from the University of Surrey has revealed that biotechnology could be the missing ingredient in helping cocoa farmers get a better deal for their beans.
Cleveland Clinic researchers have engineered a first-of-its-kind bionic arm for patients with upper-limb amputations that allows wearers to think, behave and function like a person without an amputation, according to new findings published in Science Robotics.
In recent years, scientists have developed monoclonal antibodies — proteins that mimic the body’s own immune defenses — that can combat a variety of diseases, including some cancers and autoimmune disorders such as Crohn’s disease.
Biologists at Sandia National Laboratories developed comprehensive software that will help scientists in a variety of industries create engineered chemicals more quickly and easily. Sandia is now looking to license the software for commercial use, researchers said.
طوّر باحثو مايو كلينك وزملاؤهم في معهد ماساتشوستس للتكنولوجيا (MIT) معجونًا سريع الالتصاق يمكنه إيقاف نزيف الأعضاء بشكل مستقل دون تخثر. التفاصيل منشورة في مجلة الهندسة الطبية الحيوية لنيتشر.
Pesquisadores da Mayo Clinic e colegas do Instituto de Tecnologia de Massachusetts (Massachusetts Institute of Technology, MIT) desenvolveram uma cola de selagem rápida que pode estancar o sangramento de órgãos independentemente da coagulação.
Los investigadores de Mayo Clinic y sus colegas del Instituto Tecnológico de Massachusetts (MIT, por sus siglas en inglés) elaboraron un pegamento que sella rápido y es capaz de detener el sangrado en los órganos, independientemente de la coagulación.
University of Washington and Microsoft researchers have introduced a new class of reporter proteins that can be directly read by a commercially available nanopore sensing device.
Researchers at Princeton University have built the world's smallest mechanically interlocked biological structure, a deceptively simple two-ring chain made from tiny strands of amino acids called peptides.
Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.
مدينة روتشستر، ولاية مينيسوتا— حصوات الكُلى البشرية قديمة قِدم أهرامات الجيزة على الأقل. لقد عُثر على أقدم حصوة كُلى في قماش الساتان المُستخدم في الدفن المصري تعود إلى عام 4400 قبل الميلاد. وقد قامت مايو كلينك في العام الماضي بمعالجة وتحليل حوالي 90,000 حصوة كُلى من جميع أنحاء العالم.
Los cálculos renales en los seres humanos son tan antiguos como las pirámides de Guiza y, de hecho, el cálculo renal más antiguo se encontró en un satén mortuorio egipcio del año 4400 A.C. El año pasado, Mayo Clinic procesó y analizó aproximadamente 90 000 cálculos renales procedentes de todo el mundo.
Cornell researchers have identified a new way to measure DNA torsional stiffness – how much resistance the helix offers when twisted – information that can potentially shed light on how cells work.
A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.
Imagine if you could attach something to your skin without needing glue. A biosensor, a watch, a communications device, a fashion accessory — the possibilities are endless. Thanks to a discovery at Binghamton University, State University of New York, that time could be closer than you think.
Mayo Clinic researchers and colleagues at Massachusetts Institute of Technology (MIT) have developed a rapid-sealing paste that can stop bleeding organs independent of clotting. The details are published in Nature Biomedical Engineering.
The inspiration for this paste? Barnacles.
Pharmaceutical and biotechnology companies topped the 2021 RQ Top 50 list of the most innovative U.S. companies. The annual ranking identifies the smartest R&D spenders - those companies that both spend big (at least $100 million in R&D) and provide the greatest returns to shareholders from that investment.
With the recent announcement of the RegeneratOR Test Bed to support regenerative medicine start up companies, the Wake Forest Institute for Regenerative Medicine (WFIRM) and the RegenMed Development Organization (RemDO) are embarking on the next step – to help create the future workforce.
Despite assumptions, dsRNA has traits that make it stand apart from the more common single-stranded RNA. The finding has implications for a range of fields
A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.
This transaction will expand BioIVT’s biospecimen collection network by approximately 150 sites in the US, UK, and Europe and broaden its offerings for drug and diagnostic developers.
Scientists have developed a rapid, highly accurate test to detect antibodies against the spike protein of SARS-CoV-2 in human serum, opening a new avenue for understanding the full extent of the pandemic and evaluating the effectiveness of vaccines.
The NCCN Oncology Research Program (ORP) announces projects that have been selected for funding to evaluate neratinib in various tumor types, supported by a grant from Puma Biotechnology, Inc.
Scientists have uncovered a way to control many genes in engineered yeast cells, opening the door to more efficient and sustainable production of bio-based products.
The Polo Tecnologico Piemontese (PTP) is born in Candiolo (Turin), a hub of innovative companies that will host avant-garde technological companies and research institutes dedicated to medicine and which sees the HBW Group * as the leader.
Researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.
Harrisburg University of Science and Technology and The Baruch S. Blumberg Institute have teamed to offer graduate-level biotechnology certificates to prepare working professionals with workforce and leadership skills within the biotechnology industry.
Beginning Fall 2021 semester, the Biotechnology Certificate Program will be offered in partnership with The Blumberg Institute. The Blumberg Institute is the nation’s leading translational research organization dedicated to finding a cure for hepatitis B and liver cancer.
Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.
The U.S. Department of Energy (DOE) today awarded $45.5 million for research projects geared towards understanding and harnessing nature’s biological processes to produce clean biofuels and bioproducts.
In a long career full of scientific accomplishments, Brian Davison counts among his many successes the formation of Oak Ridge National Laboratory’s LGBTQIA+ employee group and helping gay and lesbian staff at the lab navigate a sometimes tricky landscape has been among his most meaningful experiences.
Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA.
Mary Dunlop leads a team at Boston University that uses multi-disciplinary approaches to improve the amount of biofuel that certain microbes can produce. These microbes can produce replacements for gasoline, diesel, and jet fuel.
An accurate, non-invasive, and low-cost method of testing for COVID-19 using samples taken from the screens of mobile phones has been developed by a team led by UCL researchers at Diagnosis Biotech.
Jin Kim Montclare, professor of chemical and biomolecular engineering led a team who previously reported a responsive hydrogel formed using a coiled-coil protein. The team expanded their studies to identify the gelation of Q protein at distinct temperatures and pH conditions.
The American Society of Anesthesiologists (ASA) today announced Heron Therapeutics, a commercial-stage biotechnology company, as an ASA Industry Supporter for the third year, supporting the work of the Society and physician anesthesiologists to reduce reliance on opioids during or following surgical procedures and ensuring that non-opioid alternatives are available to patients.
A hydrogel that forms a barrier to keep heart tissue from adhering to surrounding tissue after surgery was developed and successfully tested in rodents by a team of University of California San Diego researchers. The team of engineers, scientists and physicians also conducted a pilot study on porcine hearts, with promising results.
They describe their work in the June 18, 2021 issue of Nature Communications.
UC San Diego School of Medicine researchers discovered that the enzyme RNA polymerase II recognizes and transcribes artificially added base pairs in genetic code, a new insight that could help advance the development of new vaccines and medicines.
GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, today announced that it will provide a corporate update at the upcoming Raymond James Human Health Innovation Conference on Tuesday, June 22, 2021 at 11:20 AM ET.
The Southwest National Primate Research Center (SNPRC) at Texas Biomed has been awarded more than $37 million from the National Institutes of Health to continue operations into 2026. The P51 grant, given by the NIH Office of Research Infrastructure Programs, provides essential funding to house and care for nearly 2,500 non-human primates that are part of life-science research programs at Texas Biomed and partners around the globe.
Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used to deliver drugs to the gastrointestinal tract, respiratory tract, or other tubular organs in the body.